`
`MAN l t-31.Z LJ MA 8
`Business Use Only
`
`Lucentis PFS (RFB002)
`
`TRD SubTeam meeting
`
`Agenda
`
`Meeting Date: Nov. 12, 2012
`Meeting Notes Date: Nov. 22, 2012
`Author:
`Room: WSJ-340.3.09
`Dial-in:
`
`D
`r,££,..,..ces.11"611
`
`Team Members :(✓ = Present, .. = part-time)
`
`Team Members : (✓ = Present, .. = part-time)
`
`I
`I
`I
`I
`I
`I
`I
`I
`I
`
`I
`
`TRD Subteam Meeting Minutes, Date of Meeting: November 12, 201 2
`
`1 of 8
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2087.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Project update:
`I
`I·
`
`Discussion
`
`Achievements
`N.A.
`Issues
`What
`N.A.
`
`1 Oen
`
`Closed
`
`TRD Subteam Meeting Minutes, Date of Meeting: November 12, 2012
`
`2 of 8
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMAT ION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2087.002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Topic/Situation
`
`Discussion
`E
`
`TRD Subteam Meeting Minutes, Date of Meeting: November 12, 2012
`
`3 of 8
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2087.003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Achieve.men.ts
`NA
`Issues
`What
`N.A.
`Actions
`
`' Topic/Situation: I
`
`•
`I
`Discussion
`
`o en
`
`Closed
`
`Pre-reads
`
`N.A.
`
`TRD Subteam Meeting Minutes, Date of Meeting: November 12, 2012
`
`4 of 8
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMAT ION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2087.004
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`What
`NA
`
`Who
`
`When
`
`Lead:
`
`Pre-reads
`
`N.A.
`
`Topic/Situation:. Project update
`
`•
`I
`
`I
`
`I
`
`Discussion
`
`TRD Subteam Meeting Minutes, Date of Meeting: November 12, 2012
`
`5 of 8
`
`CONTAINS CONFIDENT IAL BUSINESS INFORMAT ION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2087.005
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Achievements
`
`Issues
`What
`N.A.
`Actions
`
`Closed
`
`Open
`
`Who -
`
`Topic/Situation
`
`Pre-reads
`
`Discussion
`
`Achievements
`
`Issues
`What
`N.A.
`Actions
`
`Oen
`
`Closed
`
`Lead:
`
`I Pre-reads
`
`TRD Subteam Meeting Minutes, Date of Meeting: November 12, 2012
`
`6 of 8
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2087.006
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Discussion
`
`What
`N.A.
`Actions
`What
`N.A.
`
`Consolidated Action Plan
`
`n
`
`Closed
`
`Who
`I
`
`When
`
`Who
`
`--
`
`7 of 8
`
`TRD Subteam Meeting Minutes, Date of Meeting: November 12, 2012
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMAT ION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2087.007
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`TRD Subteam Meeting Minutes, Date of Meeting: November 12, 2012
`
`8 of 8
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2087.008
`Regeneron v. Novartis, IPR2021-00816
`
`